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Aims: Psychosocial factors amplify symptoms of Interstitial Cystitis (IC/BPS). While 
psychosocial self-management is efficacious in other pain conditions, its impact on an 
IC/BPS population has rarely been studied. The objective of this review is to learn the 
prevalence and impact of psychosocial factors on IC/BPS, assess baseline 
psychosocial characteristics, and offer recommendations for assessment and treatment.  
Method: Following PRISMA guidelines, primary information sources were PubMed 
including MEDLINE, Embase, CINAHL, and GoogleScholar. Inclusion criteria included: 
1) a clearly defined cohort with IC/BPS or with Chronic Pelvic Pain Syndrome provided 
the IC/BPS cohort was delineated with quantitative results from the main cohort; 2) all 
genders and regions; 3) studies written in English from 1995- April 14, 2017; 4) 
quantitative report of psychosocial factors as outcome measures or at minimum as 
baseline characteristics.  
Results: 34 of an initial 642 articles were reviewed. Quantitative analyses demonstrate 
the magnitude of psychosocial difficulties in IC/BPS, which are worse than average on 
all measures, and fall into areas of clinical concern for 7 out of 10 measures. Meta-
analyses shows mean Mental Component Score of the Short-Form 12 Health Survey 
(MCS) of 40.80 (SD 6.25, N=2912), where <36 is consistent with severe psychological 
impairment. Averaged across studies, the population scored in the range seen in clinical 
depression (CES-D 19.89, SD 13.12, N = 564) and generalized anxiety disorder (HADS-
A 8.15, SD 4.85, N = 465).  
Conclusion: The psychological impact of IC/BPS is pervasive and severe. Existing 
evidence of treatment is lacking and suggests self-management intervention may be 
helpful.  
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Psychosocial Co-Morbidities in Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS): A 
Systematic Review. 
 
Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) is a debilitating, incurable, and 
costly pain condition affecting approximately 3-8 million individuals in the United 
States1. The economic burden of the condition is substantial, costing the healthcare 









which occurs in the region of the pelvis, urogenital floor, or external genitalia. In 
addition, most patients experience urgency, pressure/discomfort, and/or urinary 
frequency3. There is a limited understanding of IC/BPS pathophysiology and most 
treatments target symptom control. Biomedically-based treatments currently lack 
effectiveness 4. Between 1992-2001 the rates of physician office visits for IC/BPS tripled 
and outpatient hospital visits doubled2.  
Evidence suggests psychosocial factors, such as co-morbid anxiety, depression, 
quality of life, and trauma-related symptoms accompany and intensify the illness5,6.  
Unaddressed psychosocial elements of chronic pain can shape patient perceptions and 
behavior, often leading to increased chronicity of symptoms and are associated with 
poorer functioning, adjustment, prognosis, and response to treatment 6-10. These 
findings suggest not only a strong association, but also that psychosocial symptoms and 
bladder-specific symptoms reinforce one another.  
Although there is a recognized need for psychosocial intervention as a first-line 
treatment for IC/BPS per national guidelines4, these interventions are difficult to 
implement in actual practice and as such they are underutilized. It is also unknown if the 
recommended therapies suggested in these guidelines sufficiently meet patient needs 
or whether patients with IC/BPS require a broader pain self-management approach as 
is used with other forms of chronic pain11. As there is paucity of randomized controlled 
trials evaluating how these interventions work and for whom, little is known about the 
impact of treating psychosocial factors on outcome.  
While much is being learned about IC/BPS through Federally-sponsored 









widespread psychosocial difficulties in IC/BPS9, there has yet to be a comprehensive 
review of the existing evidence examining psychosocial factors and IC/BPS. The 
objective of this review is to learn the prevalence and impact of psychosocial factors on 
IC/BPS, and assess baseline psychosocial characteristics. This is the first systematic 
review to our knowledge on the data available on the prevalence and impact of IC/BPS 
on psychosocial variables such as co-morbid mental health conditions, psychological 
states, and quality of life. Having this information will help future researchers 1) capture 
relevant treatment outcomes, 2) provide guidance on assessment domains, and 3) 
increase knowledge to inform treatment approaches. This systematic review 
synthesizes the existing evidence of psychosocial factors associated with IC/BPS and, 
when possible, provides additional normative data as a tool for comparison. We then 
offer recommendations for assessment and treatment.  
Methods 
Search Strategy 
We performed a systematic review of the literature in accordance with the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Framework 13. 
In consultation with a medical librarian, we established a review strategy to identify 
studies that differentiated cohorts with Interstitial Cystitis as either the primary study 
population or as a sub-cohort of analysis. The primary information sources were 
PubMed including MEDLINE, Embase, CINAHL, and Google Scholar.  
Study inclusion criteria included: 1) a clearly defined cohort with Interstitial 
Cystitis or with Chronic Pelvic Pain Syndrome provided the Interstitial Cystitis cohort 









written in English from 1995- April 14, 2017; 4) any study region; 5) quantitative report 
of psychosocial factors as outcome measures or at minimum as baseline 
characteristics. We focused on psychosocial attributes including trauma, anxiety, 
depression, panic traits or quality of life measures. The use of validated instruments or 
self-report measures was not required but was noted when present in study results. 
Search phrases were defined in MeSH and in Google Scholar and are shown 
below in Table 1.  
[TABLE 1] 
 
Identified studies were screened for duplicates and subsequently underwent title and 
abstract review according to the criteria above. The resultant corpus of studies that fit 
our inclusion criteria were then reviewed in full-text. Data items were collected for each 
study: authorship, title, journal, year of publication, study design, study inclusion criteria, 
sample size, psychosocial measure(s) or prevalence, targeted outcome(s). One 
reviewer evaluated each study in detail. In the 5 cases where there was uncertainty 




We evaluated eligible publications (total N = 34) for both qualitative and quantitative 
data. The former incorporated a review of study design, methodology, and presence of 
an intervention designed to impact psychosocial measures or whether such measures 









considered and recorded. Quantitative analyses included psychosocial measures and 
variances/standard deviations if reported.  
For studies with quantified psychosocial measures (N = 17), meta-analysis was 
performed with pooled statistics grouped by measure, e.g. SF-36, and by targeted 
outcome, e.g. trauma or abuse, if reported. We assumed equal population variances 
across studies given our inclusion criteria delineating the population with IC and 
therefore applied pooled variances with Bessel’s correction to study results. We then 
compared pooled statistics against guidelines for clinical interpretation provided for each 
measure (see Table 3). Variables were calculated if more than one study used a given 
measure. Bias assessment was informed by the Cochrane Risk of Bias Tool though we 
note that the primarily observational nature of most research in this area coupled with 
relatively small sample sizes indicated common sources of bias and precluded rigorous 
application of this tool or others like Downs and Black 14. These biases will be reviewed 
in aggregate (see Results). 
[FIGURE 1] 
Results 
Using the inclusion criteria described above, the final number of reviewed articles was 
34 out of 642 search results (see Figure 1). We have consolidated the details and 
primary findings of each study in Table 2. The review of psychosocial factors in IC/BPS 
is broken down into the following domains: depression, anxiety, stress/coping, trauma, 
quality of life, and demographic factors. We then detail findings of pooled statistics in 









evidence available on treatment studies, we do not qualitatively review them. Instead, 
we discuss the implications of their primary findings in our discussion.  
[TABLE 2] 
1. Depression 
The impact of depression on IC/BPS was assessed in 16 of 34 studies. Study measures 
primarily involved self-reported symptoms of depression, with one study evaluating 
clinical diagnoses by chart review.  Depression rates were elevated in all 16 studies, 
with prevalence rates ranging from 16-70%, fluctuating largely based on study type, 
sample size, and assessment method. Women with IC/BPS are between 2.4-6.6 times 
more likely to be diagnosed with depression than controls 15-17, and 4 times more likely 
to use psychotropic medications. Depression is consistently associated with worsened 
symptom presentation, particularly in early stages of illness 16,17. Patients who are 
depressed are less likely to work 6, and are more likely to present with polysymptomatic 
complaints 9. Helplessness, a symptom of depression, was associated with worsened 
mental functioning 18. In a recent study, 23% of patients acknowledged experiencing 
suicidal ideation, which was associated with greater pain and worsened mental health 
functioning 19.  
2. Anxiety and Panic 
Anxiety was assessed in 10 of 34 studies, with 8 assessing symptoms through self-
report measures, 2 evaluating clinical diagnoses given during medical record review, 
and 1 structured and validated clinical interview assessing for the presence of an 
anxiety disorder. Prevalence rates of anxiety symptoms in IC/BPS ranged from 14-52%. 









existing anxiety disorder prior to developing IC/BPS 20 and are 2.4 times more likely to 
develop an anxiety disorder following IC/BPS diagnosis 16. Similarly, in another study, 
panic disorder was diagnosed in 26.9% of cases, indicating that women with IC/BPS are 
4.1 times more likely than those with other urological disease to develop panic disorder 
in their lifetime – and to have first degree relatives that are twice as likely to have panic 
disorder21. Patients with anxiety also show increased urinary symptom severity and 
lower self-esteem 22. 
3. Stress and Coping  
Nine studies measured stress and coping by assessing catastrophic thought processes 
18,19,23-26, perceived stress 9,23,24, and self-efficacy 27,28. Catastrophizing, or an internal 
exaggeration of events, rumination, or sense of helplessness in response to pain, is 
consistently related to worsened outcomes in mental and physical functioning 18,19,25. In 
addition, catastrophizing increases vulnerability to suicidal ideation 19. Both genders 
show heightened generalized stress levels, often in spite of the severity of symptoms 
23,26. Those with greater self-efficacy experienced less pain and depression 28.  
4. Trauma Sequelae 
Six studies measured abuse prevalence via validated self-report 5,9,24,29, non-validated 
questionnaires 30,31, and clinical interview of trauma exposure 30.  One study measured 
dissociative tendencies 29. Overall abuse prevalence rates range from 25-49%.  Trauma 
and abuse prevalence rates range significantly by method of reporting and abuse type. 
For example, between 21-40% of patients endorsed exposure to traumatic events as a 
child on self-report questionnaires. When asked directly via clinical interview, this 









asked directly “were you abused as an adult/child,” without a definition of ‘abuse’ 5. 
Abuse in childhood and adulthood is more common in female patients 9. The presence 
of sexual abuse has been associated with altered symptom presentation, where 
patients experiencing greater sensory pain 24,31, less daytime frequency and nocturia, 
larger voided volumes, 31, and worsened sexual functioning 31,32 – although one study 
notes this relationship is at most very modest 24. 
5. Quality of Life Factors  
Twenty-one studies included a measure of quality of life. This most often included a 
broad measure on different life areas, and in some cases more specific aspects of daily 
life including insomnia, social support, self-esteem, and sexual functioning. Overall 
physical and mental quality of life is significantly impacted across the population. Quality 
of life is often worsened with increased symptom severity and co-occurring 
psychological difficulties 6,23. Self-esteem and social functioning are both significantly 
impacted by IC/BPS 22 when compared to controls. Impaired sexual functioning is a 
common occurrence in the population; however, there was evidence of hesitancy in 
reporting this to providers or on questionnaires.  
6. Demographic factors 
Age is a significant factor when considering the psychosocial impact of symptoms. 
Studies found that younger individuals have increased risk of developing psychological 
co-morbidities and insomnia following IC/BPS diagnosis 16, have significantly diminished 
quality of life 33, and are at higher risk for depression in the earlier stages of illness 17. 
This was true of both genders. These individuals are also more likely to utilize 









symptom presentation, although these results are mixed. Women are more likely to 
present with polysymptomatic complaints 9,23,34. The examination of abuse prevalence 
has occurred predominately in females.  In the most comprehensive psychological study 
to date, comparing gender, Naliboff and colleagues (2015) found that women are more 
likely to report early life and adult trauma exposure, greater helplessness, and poorer 
functionality than men – irrespective of symptom severity or age. Although there is less 
available information on men with IC/BPS, a large population-based study showed that 
younger men were at higher risk of developing depression following IC/BPS diagnosis 
16. Other studies showed no gender differences in mental health presentation 15.  
7. Quantitative Analyses 
Pooled population means and standard deviations for psychosocial variables are 
presented in Table 3, along with clinical cutoff and suggested interpretations for each 
measure. Results clearly demonstrate the magnitude of psychosocial difficulties in 
IC/BPS, which are worse than average on all measures, and fall into areas of clinical 
concern for 7 out of 10 measures when following guidelines for clinical interpretation 
(see Table 3). The population’s baseline psychological functioning is considered 
“depressed” according to two commonly used measures to assess depression. For 
example, of 564 subjects provided with the Center for Epidemiological Studies of 
Depression, or CES-D35, the mean response was 19.89. The clinical “cutoff” for this 
measure indicating extremely likely depression is 1635, or 19 in chronic pain patients.36 
Patients are much more likely to have an anxiety disorder and have stress levels of 
clinical concern. Of 465 subjects administered the Hospital Anxiety and Depression 









“8” indicates a 78% likelihood of having Generalized Anxiety Disorder37. There is 
significant impairment in quality of life in both mental (MCS = 40.80 (6.25), N = 2912) 
and physical (PCS = 42.37 (6.67), N = 2912) functioning. For mental functioning, this is 
well below population averages, and approaching “severe psychological 
impairment.38,39” Quality of life measures indicate that at baseline women are at 
significant risk of sexual dysfunction (FSFI = 16.37, SD 8.12, N = 926).  Although 
Catastrophizing scores were elevated compared to population norms, the average 
scores of the two scales did not fall in the range of clinical concern. 
[TABLE 3] [TABLE 4] 
Risk of bias in reporting and study limitations: 
Evaluating the psychosocial aspects of IC/BPS remains a relatively new area of study. 
There are limitations to note about the current literature. The most common method of 
evaluation was via self-report measures. These assessments cannot make definitive 
psychological diagnoses and are generally used as screening tools. Assessments given 
also lacked in consistency, making a collective analysis of studies difficult. Some of 
these measures did not adequately capture the outcomes assessed. For example, two 
used the Medical Outcomes Survey39 sexual functioning scale, which does not measure 
sexual pain – a common experience impacting sexual functioning in IC/BPS. Some 
assessments suffered from a low response rate, (e.g.. Female Sexual Functioning 
Index40 in mailed questionnaires from studies), and used measures lacking in validity 
30,41. There are concerns of under-reporting with trauma, abuse, and sexual dysfunction 
due to discomfort with disclosure 5,30. Roughly half of the studies lacked control groups. 









collected were often in convenience samples, with primarily white women in tertiary care 
centers. Many assessments were observational at one time point. The majority of 
studies cited did not follow patients over time. Even the treatment studies listed had 
limited, short-term follow-up. The three RCTs reported were not adequately powered to 
reliably assess for treatment effects. 
 
Discussion 
This study is the first to provide a comprehensive review of the existing evidence 
evaluating psychosocial factors in IC/BPS. We reviewed 34 studies to provide a 
synthesis of the literature and guidance for future studies.  
 The psychological and social impact of IC/BPS is pervasive. There is significantly 
increased likelihood of an anxiety or depressive disorder both preceding and following 
IC/BPS diagnosis. Symptoms of anxiety, depression, and generalized stress, and 
increased suicidal ideation are paramount. Individuals are more likely to engage in 
catastrophic thought processes, which globally worsens functioning. IC/BPS has a 
detrimental impact on quality of life, self-esteem and social functioning. Pooled statistics 
indicate that at baseline, mean scores on measures of anxiety, depression, and stress 
fall in areas of clinical concern as defined by their clinical interpretation guidelines (see 
Table 3).  
  
Implications for Assessment 
In future studies we strongly recommend using validated measures to reliably capture 









disorders associated with IC/BPS is best accomplished through a validated clinical 
interview. This was performed in one of the studies reviewed 21, and will help provide 
the most accurate and reliable assessment of conditions beyond screening measures. 
In Table 3, we provide an overview of assessments most commonly used for 
psychosocial variables in IC/BPS, with guidelines for clinical interpretation. It is our hope 
that this can serve as a guide to future researchers, while also providing benchmarks for 
clinicians and further study. Table 4 outlines recommendations for assessment of pain 
in urologic disease provided by Williams (2013). In addition to pain symptoms and 
medical co-morbidity, a comprehensive assessment includes affective vulnerability, 
patient beliefs and attitudes, and a patient’s environment/social relationships. Many of 
the recommended assessments in Table 4 were not available for meta-analysis (used in 
<2 studies reviewed) or had not been used. In the future we recommend expanding on 
current research by using this reference as a guideline to structure a comprehensive 
assessment in clinical studies of IC/BPS.  
Trauma exposure: While a relationship between trauma exposure and IC/BPS 
has been established in studies to date, the nature and impact of the association has 
yet to be fully elucidated. Future studies are in need of comprehensively assessing 
trauma across the lifespan, and simultaneously assessing active symptoms of post-
traumatic stress disorder (PTSD). Of the studies reviewed, no studies evaluated active 
symptoms of PTSD. Post-traumatic stress is known to exacerbate and maintain pain 










In one study, 29 of 30 women with childhood sexual abuse did not report this to 
their doctor 5. Abuse exposure should be routinely assessed in clinical settings. As this 
is a difficult topic to broach with patients, a more appropriate screening measure may be 
to evaluate symptoms associated with trauma exposure – as opposed to direct 
questioning. This is employed in primary care settings with measures such as the 4-item 
Primary Care – PTSD Screen (PC-PTSD42) and may reduce discomfort with direct 
disclosure.  
Treatment Implications 
The demographic findings detailed above suggest that the early stages of illness are a 
particularly vulnerable period. Early access to psychological intervention may interrupt 
the development of these conditions, which could have important implications for illness 
prognosis. Gender differences may also impact symptom presentation and treatment 
approach. A recent review examining Chronic Prostatitis/Chronic Pelvic Pain Syndrome 
(CP/CPPS) found elevated prevalence rates of depression and anxiety disorder, but not 
panic disorder among patients 43. This suggests that treatment approaches may have 
different targets of intervention depending on gender – however, further studies are 
needed to clarify these differences. 
 From evidence provided in this review, it is clear that untreated psychosocial 
factors worsen symptom presentation and prognosis. Untreated psychosocial co-
morbidities may significantly impact the treatment process as well. Depressed patients 
are known as less likely to follow treatment recommendations. Helplessness and 
Catastrophizing influence patient behavior, lack of agency, and over-reliance on 









sexual abuse history and/or PTSD, routine exams, urologic diagnostic procedures, 
and/or manual physical therapy have the potential to be re-traumatizing44.  
Accompanying recommendations from the AUA regarding first-line interventions for 
IC/BPS, the most recent National Pain Strategy (2015) highlights the importance of 
taking a integrated, multimodal approach to managing pain in order to address the 
biopsychosocial factors influencing pain. The inclusion of a mental health provider into a 
multimodal treatment plan for IC/BPS has the potential to improve symptoms, quality of 
life, and treatment adherence. 
 
Findings of self-management interventions 
Of the three investigations to date, there are initial indications that self-management 
strategies have the ability to significantly improve symptoms and wellbeing in IC/BPS. 
Each study utilized a different approach – guided imagery/self-hypnosis 27, mindfulness 
46, and online health education 47. Although these investigations were all pilot studies 
and had limited follow-up, the findings are promising. Those treated reported significant 
reductions in pain and urinary urgency46,47, had greater perceived control of symptoms 
46, and better healthcare outcomes than controls 47.  The impact of these interventions 
on psychological states and co-morbidity has yet to be assessed.  
A large proportion of the studies in this review urge the integration of 
psychological assessment and management into care plans for IC/BPS. Psychosocial 
self-management interventions could benefit patients through bolstering self-efficacy 
and increasing social support - which are known to buffer the impact of symptoms 28,48, 









morbidities that intensify the illness.  These interventions may also be preferable as 
patients are often not responsive to psychotropic medications 15. As psychological 
distress occurs across patient phenotype 9,26, and many patients with only moderate 
symptoms have significant psychological burden 9,49, patients at all stages of the illness 
could benefit. A recent survey conducted in collaboration with the Interstitial Cystitis 
Association (N = 1,982; 50) revealed that there is significant interest in and perceived 
benefits of employing self-management strategies such as stress reduction, sleep 
hygiene, relaxation, and meditation as well as engaging in active coping strategies to 
alleviate symptoms. This is a new area of clinical investigation with significant potential 
which patients are open to. Future well-controlled studies with larger sample sizes, 
comprehensive assessment, and long-term follow up are indicated.    
 
Strengths and limitations of review 
This study accumulates previous literature and presents the best available evidence for 
the associations between and impact of psychological co-morbidities and IC/BPS. A 
strength of the current study is its comprehensive and reproducible search strategy. A 
limitation of this review is our inability to perform a true meta-analysis due to the limited 
literature available. Future studies are needed with longer-term follow-up and larger 
sample sizes. In addition comprehensive psychosocial assessment, including an 
assessment of PTSD symptoms is recommended. We believe that continued self-
management intervention research is necessary based on the preliminary information 
available. We suspect that given the emerging evidence of a patient phenotype, 









The study of IC/BPS has largely been limited to females. As research is leaning 
towards conceptualizing IC/BPS and CP/CPPS as a unified condition (“UCPPS”12), 
examining the literature in both conditions may provide more information regarding 
gender differences and treatment individualization.  
 
Conclusion 
The psychological impact of IC/BPS is pervasive and severe. Existing evidence 
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Figure and Table Captions: 
 














HC Healthy Control 
*  
Outcome data 
reported on IC/BPS 
cohort only 
NR Not reported 
W White 
Hisp Hispanic 









UD Urologic Disorders 
AC Acute Cystitis 
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Center for Epidemiological Studies of 
Depression 
BDI-II Beck Depression Inventory 
HADS-A/D Hospital Anxiety and Depression Scale 
PSS Perceived Stress Scale 
CSQ Coping Strategies Questionnaire 
PCS Pain Catastrophizing Scale 
PCS Physical Composite Scale 
MCS Mental Composite Scale 
FSFI Female Sexual Functioning Index 
 
 
Table 4 Legend 
Abbreviation Described 
CES-D 
Center for Epidemiological Studies of 
Depression 
STAI State Trait Anxiety Inventory 
STAXI State Trait Anger Expression Inventory 
HADS Perceived Stress Scale 
PANAS Positive and Negative Affect Scale 
BPCQ Beliefs in Pain Control Questionnaire 
CSQ Coping Strategies Questionnaire 
SEQ Self-Efficacy Questionnaire 
PCS Pain Catastrophizing Scale 
DAS Dyadic Adjustment Scale 
WHYMPI 
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Information Source Search Phrase 
PubMed, MEDLINE, Embase, CINAHL ("Cystitis, Interstitial" OR interstitial cystitis OR bladder pain syndrome OR 
mapp network OR chronic prostatitis with chronic pelvic pain syndrome OR 
chronic pelvic pain syndrome) AND ("Anxiety" OR anxiety OR "Depression" 
OR "Depressive Disorder" OR depression OR "Sleep Initiation and 
Maintenance Disorders" OR insomnia OR "Quality of Life" OR "Stress 
Disorders, Post-Traumatic" OR quality of life OR post-traumatic stress 
disorders OR "Health Promotion" OR "Psychology" OR psychosocial OR 
health promotion OR psychology) AND (Clinical Trial OR Comparative Study 
OR Evaluation Studies OR Meta-Analysis OR Observational Study OR 
systematic) 
 
NOT (drugs OR medications OR prescriptions OR pharmaceutica
Google Scholar (title search only) Search #1: Interstitial cystitis depression OR anxiety OR trauma OR abuse 
OR "post traumatic stress disorder"  
 
Search #2: bladder pain syndrome OR depression OR anxiety OR trauma 
OR "post traumatic stress disorder"  
Author 
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Table 3: Pooled Statistics of Psychosocial Variables with Outpatient Comparison 
Measure Total N 
Mean 
(SD) Clinical Cutoffs & Interpretation 




>16.0 cutoff for clinical depression37, >19 for clinical depression in 
chronic pain38 
BDI-II 234 14.28 (8.51) >14 mild depression, >20 moderate, >29 severe depression 
HADS-D 465 5.65 (4.40) >8 detects major depression 
53 
Anxiety, Stress, and 
Coping       
HADS-A 465 
8.15 
(4.85) >8 indicates 78% chance of having generalized anxiety disorder
PSS 659 18.61 (8.61) 
>16 high health concern, >20 considered very high health conce
need of intervention54  
CSQ - CAT 466 
14.15 
(8.60) 
>20 indicates high catastrophizing where patients are at greater risk 
for worse health outcomes55 
PCS - Catastrophizing 503 
22.07 
(12.45) 
Mean score is 20, >30 indicates clinically significant level of 
catastrophizing56 
Quality of Life       
PCS (SF-12 and SF-36) 2912 42.37 
(6.67) 
< 47 below average physical health for U.S. population57 
MCS (SF-12 and SF-36) 2912 40.80 
(6.25) 
</= 45 likely depression, </= 50 likely anxiety disorder, <36 indicates
severe psychological impairment58 
FSFI 926 
16.37 








Table 4: Recommended Psychosocial Assessment Instruments for pain in urologic disease 
Domain Purpose Instrument Included in meta-analysis 
Affective Vulnerability Depressed Mood CES-D Yes 
  Anxious Mood STAI No 
  Anger STAXI No 
  Combination: depression/anxiety HADS Yes 
  Combination: negative/positive affect PANAS No 
Beliefs and Attitudes Locus of Pain Control BPCQ No 
  Coping Strategies CSQ Yes 
  Self-efficacy SEQ No 
  Catastrophizing PCS Yes 
Environmental/social Marital satisfaction DAS No 









Note: Table adapted from "The importance of psychological assessment in chronic pain," by D. Williams, 
2013, Current Opinion in Urology 23 (6),554-560. p55660 
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